Risks of severe hyponatremia in children receiving hypotonic fluids.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 27 01 2020
revised: 07 06 2020
accepted: 13 08 2020
pubmed: 9 10 2020
medline: 24 8 2021
entrez: 8 10 2020
Statut: ppublish

Résumé

Intravenous fluids are frequently used in hospitalized children. Hypotonic fluids have been the standard of care in pediatrics for many years. This might be explained by the empiricism of early recommendations favoring fluids with dextrose, but an insufficient amount of sodium. The risk of hyponatremia (<135mmol/L) might be increased by the occurrence of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in the course of common acute diseases (e.g., bronchiolitis, acute gastroenteritis, encephalitis, meningitis) in children. Severe hyponatremia (<130mmol/L) is often associated with neurologic complications leading to sequelae or even death. Over the last few years, hyponatremia induced by hypotonic fluids has been increasingly reported, and significant progress has been made in the understanding of cerebral edema and osmotic demyelination. Several randomized clinical trials have shown weak but significant evidence that isotonic fluids were superior to hypotonic solutions in preventing hyponatremia. However, clinical practices have not changed much in France, as suggested by the analysis of intravenous fluids ordered from the Assistance Publique-Hôpitaux de Paris (AP-HP) central pharmacy (PCH) in 2017. Therefore, it would be advisable that national guidelines be released under the French Health Authorities regarding the safe infusion of infants and children.

Identifiants

pubmed: 33028494
pii: S0929-693X(20)30197-4
doi: 10.1016/j.arcped.2020.08.009
pii:
doi:

Substances chimiques

Hypotonic Solutions 0
Isotonic Solutions 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-479

Informations de copyright

Copyright © 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

J-C Mercier (JC)

Université de Paris (Paris Diderot), Paris, France. Electronic address: jean-christophe.mercier@sfr.fr.

L Titomanlio (L)

Service des urgences pédiatriques, Hôpital Robert Debré, Paris, France.

R Basmaci (R)

Service de pédiatrie-urgences, Hôpital Louis Mourier, Paris, France.

J Gaschignard (J)

Service de pédiatrie générale, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH